← Insider buys
UTHR

United Therapeutics Corporation · Healthcare

Chair and CEO Martine A Rothblatt sold $5.2M of United Therapeutics Corporation

Sold$5,231,666
$550.70Price
9,500Shares
−3%Stake

What UTHR did after the filing

Filed Oct 13Copier in Oct 14
The stock from Wed, Oct 14 open, $543.18
0.0%
S&P 500, same days
−1.1%

3 of 30 trading days so far, to the Oct 19 close.

Traded Mon, Oct 12. Filed Tue, Oct 13, 4:31 PM ET, after the close. Returns use the Oct 14 open and the Oct 19 close. Not investment advice.